| Company Name: | HealthTronics, Incorporated | | Ticker Symbol: | HTRN | | | WWW Address: | www.healthtronics.com | | CEO: | James S.B. Whittenburg | | No. of Employees: | 550 | | Common Issue Type: | CS | | Business Description: | The Company provides healthcare services and manufactures medical devices, mainly for the urology community.
|
| | | Industry Information: | HEALTH SERVICES - Medical Appliances & Equipment [more like this] |
|
| Price | Day Change | Bid | Ask | Open | High | Low | Volume | | 2.36 |  -0.02 | 2.02 | 2.72 | 2.37 | 2.42 | 2.32 | 8137 |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 105.5 | 44.7 | 1.81 | -3.53 | 0.00 | 0.0 | 0.0 | 2.80 - 1.09 |
|
| KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 2.36 | $ | | PE Ratio - LTM | 0.0 | |
| Market Capitalisation | 105.4 | mil |
| Latest Shares Outstanding | 44.7 | mil |
| Earnings pS (EPS) | -3.53 | $ |
| Dividend pS (DPS) | 0.00 | ¢ |
| Dividend Yield | 0.0 | % |
| Dividend Payout Ratio | 0 | % |
| Revenue per Employee | 301,713 | $ |
| Effective Tax Rate | 0.0 | % |
| Float | 40.2 | mil |
| Float as % of Shares Outstanding | 90.1 | % |
| Foreign Sales | 0 | mil |
| Domestic Sales | 0 | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 12.50 | % |
| Research & Devlopment (R&D) as % of Revenue | 0.00 | % |
| Gross Profit Margin | 46.0 | % |
| EBITDA Margin | 33.5 | % |
| Pre-Tax Profit Margin | -41.9 | % |
| Assets Turnover | 0.6 | % |
| Return on Assets (ROA) | -47.5 | % |
| Return on Equity (ROE) | 0.0 | % |
| Return on Capital Invested (ROCI) | -88.9 | % |
| Current Ratio | 0.9 | |
| Leverage Ratio (Assets/Equity) | 1.9 | |
| Interest Cover | 0.0 | |
| Total Debt/Equity (Gearing Ratio) | 0.37 | |
| LT Debt/Total Capital | 2.0 | % |
| Working Capital pS | -0.12 | $ |
| Cash pS | 0.25 | $ |
| Book-Value pS | 2.96 | $ |
| Tangible Book-Value pS | -0.46 | $ |
| Cash Flow pS | -2.59 | $ |
| Free Cash Flow pS | -0.68 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 0.80 | |
| Price/Tangible Book Ratio | -5.19 | |
| Price/Cash Flow | -0.9 | |
| Price/Free Cash Flow | -3.5 | |
| P/E as % of Industry Group | 0.0 | % |
| P/E as % of Sector Segment | 0.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Type of Payment | - |
| Dividend Rate | 0.00 |
| Current Dividend Yield | 0.0 |
| 5-Y Average Dividend Yield | 0.0 |
| Payout Ratio | 0.0 |
| 5-Y Average Payout Ratio | 0.0 |
| |
| |
| |
| |
| |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | |
| |
| PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | 0.4 | 99 | 272 | 973 |
| 4 Weeks | 2.45 | 2.18 | 2.29 | 3.1 | 96 | 347 | 6,239 |
| 13 Weeks | 2.69 | 2.10 | 2.52 | -6.3 | 87 | 531 | 32,908 |
| 26 Weeks | 2.80 | 1.35 | 1.61 | 46.6 | 121 | 983 | 123,875 |
| 52 Weeks | 2.80 | 1.09 | 1.35 | 74.8 | 141 | 853 | 213,210 |
| YTD | 2.80 | 1.22 | - | 4.9 | 85 | 881 | 200,900 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 2.36 | 2.36 | 2.35 | 2.11 | 1.92 | 1.81 | 1.84 |
|
| |
| GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | -2.37 | 3.0 | 3.57 |
| Income | 0.00 | 0.0 | 0.00 |
| Dividend | 0.00 | 0.0 | 0.00 |
| Capital Spending | 35.61 | NA | 69.94 |
| R&D | 0.00 | NA | 0.00 |
| Normalized Inc. | 50.87 | NA | 68.61 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | 11.3 | 5.6 | 18.2 |
| Earnings % | -100.0 | -100.0 | 0.0 |
| EPS % | -100.0 | -100.0 | 0.0 |
| EPS $ | -0.11 | -0.10 | -3.12 |
|
| |
| SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | 19.38 |
| Current Ratio | 3.5 |
| Quick Ratio (Acid Test) | 2.8 |
| Liquidity Ratio (Cash) | 1.25 |
| Receivables Turnover | 6.2 |
| Average Collection Period | 58 |
| Working Capital/Equity | 38.0 |
| Working Capital pS | 1.21 |
| Cash-Flow pS | -3.09 |
| Free Cash-Flow pS | 0.25 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | -0.48 |
| Financial Leverage Ratio (Assets/Equity) | 2.0 |
| Debt Ratio | 49.1 |
| Total Debt/Equity (Gearing Ratio) | 0.39 |
| LT Debt/Equity | 0.37 |
| LT Debt/Capital Invested | 59.3 |
| LT Debt/Total Liabilities | 38.2 |
| Interest Cover | 0.0 |
| Interest/Capital Invested | 0.50 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 7.08 |
| Tobin's Q Ratio | 0.45 |
| Current P/E Ratio - LTM | 0.00 |
| Enterprise Value (EV)/EBITDA | 2.81 |
| Enterprise Value (EV)/Free Cash Flow | 25.94 |
| Dividend Yield | 0.0 |
| Price/Tangible Book Ratio - LTM | -5.19 |
| Price/Book Ratio - LTM | 0.80 |
| Price/Cash Flow Ratio | -0.9 |
| Price/Free Cash Flow Ratio - LTM | -3.5 |
| Price/Sales Ratio | 0.59 |
| P/E Ratio (1 month ago) - LTM | 0.0 |
| P/E Ratio (26 weeks ago) - LTM | 0.0 |
| P/E Ratio (52 weeks ago) - LTM | 0.0 |
| 5-Y High P/E Ratio | 0.0 |
| 5-Y Low P/E Ratio | 0.0 |
| 5-Y Average P/E Ratio | 0.0 |
| Current P/E Ratio as % of 5-Y Average P/E | 0 |
| P/E as % of Industry Group | 0.0 |
| P/E as % of Sector Segment | 0.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 3.2 |
| PER SHARE FIGURES |
| LT Debt pS | 1.17 |
| Current Liabilities pS | 0.49 |
| Tangible Book Value pS - LTM | -0.46 |
| Book Value pS - LTM | 2.96 |
| Capital Invested pS | 3.66 |
| Cash pS - LTM | 0.25 |
| Cash Flow pS - LTM | -2.59 |
| Free Cash Flow pS - LTM | -0.68 |
| Earnings pS (EPS) | -3.53 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | 5.77 |
| Free Cash Flow Margin 5YEAR AVG | 17.88 |
| Net Profit Margin | -77.6 |
| Net Profit Margin - 5YEAR AVRG. | -13.7 |
| Equity Productivity | 1.39 |
| Return on Equity (ROE) | 0.0 |
| Return on Equity (ROE) - 5YEAR AVRG. | 0.0 |
| Capital Invested Productivity | 1.02 |
| Return on Capital Invested (ROCI) | -78.8 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | -9.1 |
| Assets Productivity | 0.60 |
| Return on Assets (ROA) | -54.9 |
| Return on Assets (ROA) - 5YEAR AVRG. | -6.6 |
| Gross Profit Margin | 46.0 |
| Gross Profit Margin - 5YEAR AVRG. | 41.9 |
| EBITDA Margin - LTM | 33.5 |
| EBIT Margin - LTM | -41.1 |
| Pre-Tax Profit Margin | -51.8 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | 6.3 |
| Effective Tax Rate | 13.4 |
| Effective Tax Rate - 5YEAR AVRG. | -1.3 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | 108 |
| Revenue per Employee | 301,713 |
| Net Income per Employee | -233,987 |
| Average Collection Period | 63 |
| Receivables Turnover | 6.2 |
| Day's Inventory Turnover Ratio | 45 |
| Inventory Turnover | 7.9 |
| Inventory/Sales | 5.3 |
| Accounts Payble/Sales | 3.90 |
| Assets/Revenue | 1.67 |
| Net Working Capital Turnover | 3.65 |
| Fixed Assets Turnover | 0.97 |
| Total Assets Turnover | 0.6 |
| Revenue per $ Cash | 7.26 |
| Revenue per $ Plant | 5.06 |
| Revenue per $ Common Equity | 1.39 |
| Revenue per $ Capital Invested | 1.02 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 12.1 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 6.7 |
| Research & Devlopment (R&D) as % of Revenue | 0.0 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 0.0 |
|
|  
|
| |
 |  |